Company Analysis
Sign in

Fortress Biotech, Inc. (FBIO)

Nasdaq: FBIO · Pharmaceutical Preparations · Bay Harbor Islands, FL · filing with the SEC since 2008
Full chart Alerts Compare
Grade5.1
◀ Past 5.0● Present 5.9▶ Future 4.3
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

1 patent granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Fortress Biotech, Inc.’s names, not what it holds today.

Patents granted
1
1 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
5
since 2001, to Dec 31, 2025
Names they are printed under
4
its own name, a subsidiary
By yearGrantedApplications published
'22'23'24
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Fortress Biotech, Inc. its own name
named as the applicant on its applications, in US
0 granted
2 published
Oncogenuity, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
2 published
Cyprium Therapeutics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Fortress Biotech, Inc. its own name
US, as the owner printed on each patent
1 granted
0 published
Names not counted (4)
Journey Medical Corporation
Counted on the file of Journey Medical Corp, whose own name it is. 0 granted and 12 published under it are not counted.
Journey Medical Corporation
Counted on the file of Journey Medical Corp, whose own name it is. 6 granted and 0 published under it are not counted.
Mustang Bio, Inc.
Counted on the file of MUSTANG BIO, INC., whose own name it is. 0 granted and 4 published under it are not counted.
Mustang Bio, Inc.
Counted on the file of MUSTANG BIO, INC., whose own name it is. 0 granted and 4 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jul 5, 202211,376,263Cyproterone acetate compositions and uses thereofPharmaceuticalsFortress Biotech, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Aug 8, 20242024/0262829PEPTIDE NUCLEIC ACIDS, SYNTHESIS, AND USES THEREOFOrganic fine chemistryOncogenuity, Inc.
May 2, 20242024/0139236COPPER HISTIDINATE COMPOSITIONS AND USES THEREOFPharmaceuticalsCyprium Therapeutics, Inc.
Aug 3, 20232023/0242588METHODS AND COMPOSITIONS FOR TREATING SARS-COV-2 INFECTION USING PEPTIDE NUCLEIC ACID-BASED AGENTSBiotechnologyOncogenuity, Inc.
Oct 6, 20222022/0313705CYPROTERONE ACETATE COMPOSITIONS AND USES THEREOFPharmaceuticalsFortress Biotech, Inc.
Apr 14, 20222022/0110947CYPROTERONE ACETATE COMPOSITIONS AND USES THEREOFPharmaceuticalsFortress Biotech, Inc. · patent 11,376,263 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 1 · Organic fine chemistry 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton FBIO · research, not advice